全球硫酸酯酶市场：2023-2028 年预测

硫酸酯酶市场预计在预测期内将以 6.51% 的年复合成长率成长。

硫酸酯酶市场预计在预测期内将以稳定的速度成长。硫酸酯酶在硫酸盐代谢中扮演重要角色。人体内硫酸酯酶缺乏会导致多种疾病，包括溶小体储存障碍。不断增加的疾病和持续的科学研究预计将推动硫酸酯酶市场的成长。此外，技术的采用和对食品安全的日益关注预计将扩大硫酸酯酶的市场规模。

製药业不断增长的需求

硫酸酯酶由于能够合成活性药物成分的中间体，因此在製药工业中非常有用。最近，两种抑制SARS-Cov-2的抗病毒药物RPI-27和RPI-28源自岩藻依聚醣（一种硫酸酯酶）。在动物中，硫酸酯酶缺乏会导致先天性缺陷，例如内臟症状、HS累积和异染缺陷。治疗这些疾病需要使用硫酸酯酶，它可作为催化酶。这种在製药业的使用带来了巨大的好处，预计将推动硫酸酯酶市场的成长。

扩大硫酸酯酶的应用将推动市场成长

硫酸酯酶用于多种行业，包括製药、农业、石油和化学工业、清洁剂、生物燃料生产以及造纸和纸浆工业。由于其具有去除脂肪和油污的化学特性，它被用于清洁剂中。此外，它还分解环境中存在的含硫化合物和细胞溶酶体中的醣脂。在海洋环境中，磷酸酶充当生物催化剂，将丰富的硫酸化藻多醣代谢转化为单醣，然后进入产生能量的代谢途径。硫酸酯酶在各个领域的大量使用预计将在预测期内增加硫酸酯酶的市场规模。

农业部门需求的增加将推动成长

随着人口的增加，对农产品的需求也随之增加。根据联合国粮食及农业组织预测，2050年，粮食需求将增加50%。硫酸酯酶在农业领域中用作分解土壤中存在的芳香族硫酸酯、酚类和硫酸盐的酶。十字花科植物使用芥子油苷硫酸酯酶来保护自己免受食草动物、昆虫和其他生物的侵害，从而提高产量。植物利用将芥子油苷转化为惰性的脱硫芥子油苷的策略来对抗以叶子和茎为食的昆虫。硫酸酯酶在农业领域的这些优势预计将扩大硫酸酯酶的市场规模。

持续的研究和技术进步是成长背后的动力。

硫酸酯酶市场正在进行一些研究计划和实验。 Sulfatlas 是索邦大学开发的硫酸酯酶资料库，于 2013 年发布。目前，Sulfatlas资料库包含超过 150 万个可用的硫酸酯酶序列。 2021年10月，国家生物技术资讯中心的研究表明，肠道细菌利用黏蛋白糖蛋白需要单一的硫酸酯酶。此外，研究表明，单一硫酸酯酶对于体外和体内的聚醣利用至关重要。近年来，硫酸酯酶由于与人类代谢过程和病理学条件相关，在药物研究、兴奋剂控制分析和代谢组学中变得更加有用。硫酸酯酶在各种製程中的使用的此类研究和发现预计将推动硫酸酯酶市场的发展。

市场机会

不断的研究和实验以发现硫酸酯酶在各个方面的潜力，正在为硫酸酯酶市场创造成长机会。此外，政府投资和主要市场相关人员采用物联网来增强硫酸酯酶产品并快速开拓市场也是硫酸酯酶市场的主要成长机会。意识的提高和健康相关问题加上发育异常案例的增加，预计将为硫酸酯酶市场提供积极的成长机会。

北美可望成为重要市场

预计北美地区将在硫酸酯酶市场中占据很大的份额和显着的份额。造成这一巨大份额的因素包括生物技术领域蛋白质工程的最新进展、其他相关技术的进步、政府资助的配合措施和研究计划。此外，Compass Minerals、3M 和 Abbott Laboratories 等各种作物科学和医疗保健巨头将硫酸酯酶纳入其生产中，也使北美成为硫酸酯酶市场的主要贡献地区。

硫酸酯酶市场的主要企业

• Novozymes 成立于 1983 年，是供应工业酵素和微生物的最大生物技术公司之一。该公司提供改变工业和消费流程的生物解决方案。该公司提供的产品有重组胰岛素、CTAB、西曲溴铵和苯扎氯铵。拜耳股份公司为每位农民提供量身订製的解决方案。透过 Aleve、Alka Seltzer、Bepanthen、Acceleron、Afrin 和 Adempas 等品牌，我们提供作物保护、永续农业技术和医疗保健方面的解决方案。住友化学是一家总部位于日本的公司，在基本化学品和塑胶、能源和功能材料、IT化学品、健康和作物科学以及製药等领域提供解决方案。我们提供橡胶助剂、造纸树脂、Sumikasuper LCP、医用薄膜、Sumiploy、Sumitho L饲料添加剂等。

主要市场开拓

• 2022 年 9 月，华盛顿州立大学药学院进行的研究发现了一种名为硫酸酯酶-2 的蛋白质，可用于缓解类风湿性关节炎的症状。这项研究也为开髮用于预防骨质流失、软骨损伤和关节畸形的硫酸酯酶 2治疗方法铺平了道路。

目录

第1章简介

• 市场概况
• 市场定义
• 调查范围
• 市场区隔
• 货币
• 先决条件
• 基准年和预测年时间表

第2章调查方法

• 调查资料
• 先决条件

第3章执行摘要

• 研究亮点

第4章市场动态

• 市场驱动因素
• 市场抑制因素
• 波特五力分析
• 产业价值链分析

第5章硫酸酯酶的全球市场：依功能分类

• 介绍
• 荷尔蒙调节
• 细胞分解
• 讯号传导途径的调节

第6章全球硫酸酯酶市场：依应用分类

• 介绍
• 荷尔蒙依赖性癌症
• 溶小体贮积症
• 发育异常
• 细菌致病机制

第7章全球硫酸酯酶市场：依最终用户分类

• 介绍
• 医院
• 门诊手术中心
• 其他的

第8章全球硫酸酯酶市场：按地区

• 介绍
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 其他的
• 中东/非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 以色列
  • 其他的
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第9章竞争环境及分析

• 主要企业及策略分析
• 市场占有率分析
• 合併、收购、协议和合作

第10章公司简介

• Bayer AG（Germany）
• BASF SE（Germany）
• Yara International（Norway）
• Compass Minerals（US）
• Sumitomo Chemicals（Japan）
• UPL（India）
• Israel Chemical Company（Israel）
• Novozymes A/S（Denmark）
• Syngenta Crop Protection AG（Switzerland）

The global sulfatases market is estimated to grow at a CAGR of 6.51% during the forecast period.

The global sulfatases market is expected to grow at a steady pace during the forecast period. Sulfatases play a crucial role in sulfate metabolism. The deficiency of sulfatases in the human body causes various diseases including Lysosomal storage disorders. The rising diseases and continuous scientific research are anticipated to boost the sulfatases market growth. Further, the technological adoption and growing concern about food safety are supposed to propel the sulfatases market size.

Growing Need in the Pharmaceuticals Industry

The sulfatases are extremely useful in the pharmaceutical industry due to their property of synthesizing intermediates in active pharmaceutical ingredients. Recently, two anti-viral drugs RPI -27 and RPI-28 that inhibit SARS-Cov-2 were derived from fucoidans (sulfatase enzyme). There are congenital disorders occurrence in animals such as visceral manifestation, HS accumulation, and metachromatic disorders caused by deficiency of sulfatases. For the treatment of these disorders, the use of sulfatases is necessary as it acts as a catalyst enzyme. This usage in the pharmaceutical industry with phenomenal benefits is expected to boost the sulfatases market growth.

Wider Application use of these sulfatases will drive market growth

Sulfatases are used for their properties in various industries such as pharmaceutical, agriculture, oil and chemical industry, detergents, biofuel production, and paper and pulp industry. Due to its chemical property to remove fat and oil stains, it is used in detergents. Moreover, it degrades sulfur-containing compounds that are present in the environment and the degradation of glycolipids in the lysosome of cells. Sufatases act as a biocatalyst in the marine environment by metabolically transforming abundant sulfated algal polysaccharides into monosaccharides. These monosaccharides can enter energy-yielding metabolic pathways. The multiple uses of sulfatases in various sectors are contemplated to boost the sulfatase market size during the forecasted year.

Growing Demand in the Agriculture Sector will act as a growth driver

The demand for agricultural products is increasing with the growing population. According to the UN Food and Agricultural Organization, the food demand will increase by 50% by the year 2050. Sulfatases are used in the agriculture sector as an enzyme that breaks down aromatic sulfate esters phenols and sulfate present in the soil. The glucosinolate sulfatases are used by cruciferous plants to defend themselves from herbivory, insects, and other organisms thereby increasing the yield. The strategy to convert glucosinolate into inactive desulfoglucosinolates is used by plants against phloem-feeding insects. These advantages of sulfatases in the agricultural sector are supposed to propel the sulfatases market size.

Constant Research and Technological Advancements are further acting as growth drivers

Several research projects and experiments are happening in the sulfatases market. Sulfatlas is a database of sulfatases developed by Sorbonne University and released in 2013. Currently, the Sulfatlas database contains more than 1.5 lakh entries of available sulfatase sequences. In October 2021, a study by the National Centre for Biotechnology Information showed that a single sulfatase is required to utilize mucin glycoproteins by gut bacteria. Moreover, research has shown that single sulfatase is essential to utilize glycans in vitro and in vivo. Recently, sulfatases have been found to be of greater utility in the investigation of drugs, doping control analysis, and metabolomics due to their link between metabolic processes and pathophysiological conditions in humans. This research and the discovery of utilization of sulfatases in various processes are contemplated to boost the sulfatases market.

Opportunities in the market

The continuous research and experiments to discover the potential of sulfatases in all possible ways are providing growth opportunities in the sulfatases market. Moreover, the government investments and adoption of the Internet of Things by the major market players to enhance their products using sulfatases and rapid development is another major growth opportunity in the sulfatase market. The rising awareness and the health-related issues coupled with the rising cases of developmental abnormalities are further expected to provide a positive growth opportunity in the sulfatases market.

North America is expected to emerge as a significant market

The North American region is expected to contribute a major share and significant share in the global sulfatases market. Various factors attributing to the significant share are recent advancements of protein engineering in the biotechnology sector, other related technological advancements, government-backed initiatives, and research projects. Moreover, the presence of various crop science companies and healthcare leading companies such as Compass Minerals, 3M, Abbott Laboratories, and others which inculcate sulfatases in their production makes North America a major contributing region in the sulfatases market.

Sulfatases Market Key Players

• Novozymes established in 1983 is one of the largest biotechnology companies that supply industrial enzymes and microorganisms. The company provides bio-solutions that transform industrial and consumer processes. The product offered by the company is recombinant insulin, CTAB, cetrimide, and benzalkonium chloride.
• Bayer AG provides tailored solutions to each farmer. It offers crop protection, sustainable farming techniques, and healthcare solutions through Aleve, Alka Seltzer, Bepanthen, Acceleron, Afrin, Adempas, and several other brands.
• Sumitomo Chemicals is a Japan-based company that provides solutions in essential chemicals and plastics, energy and functional material, IT-related chemicals, health and crop sciences, and pharmaceuticals. The company offers rubber chemicals, paper processing resins, Sumikasuper LCP, medical films, sumiploy, Summit-L feed additives, and others.

Key Market Developments

• In September 2022, a study conducted by WSU College of Pharmacy identified a protein known as sulfatase-2 that is used to ease rheumatoid arthritis symptoms. This research also opens the way for the development of therapies with sulfatase-2 to prevent bone loss, cartilage damage, and deformed joints.

Segmentation:

By Function

• Hormone Regulation
• Cellular Degradation
• Modulation of Signalling Pathways

By Application

• Hormone-Dependent Cancers
• Lysosomal Storage Disorders
• Developmental Abnormalities
• Bacterial Pathogenesis

By End-User

• Hospitals
• Ambulatory Surgical Centres
• Others

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Assumptions

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Force Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. GLOBAL SULFATASES MARKET BY FUNCTION

• 5.1. Introduction
• 5.2. Hormone Regulation
• 5.3. Cellular Degradation
• 5.4. Modulation of Signalling Pathways

6. GLOBAL SULFATASES MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Hormone-Dependent Cancers
• 6.3. Lysosomal Storage Disorders
• 6.4. Developmental Abnormalities
• 6.5. Bacterial Pathogenesis

7. GLOBAL SULFATASES MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Ambulatory Surgical Centres
• 7.4. Others

8. GLOBAL SULFATASES MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. United States
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. United Kingdom
  • 8.4.2. Germany
  • 8.4.3. France
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. The Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Israel
  • 8.5.4. Others
• 8.6. Asia Pacific
  • 8.6.1. Japan
  • 8.6.2. China
  • 8.6.3. India
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations

10. COMPANY PROFILES

• 10.1. Bayer AG (Germany)
• 10.2. BASF SE (Germany)
• 10.3. Yara International (Norway)
• 10.4. Compass Minerals (U.S.)
• 10.5. Sumitomo Chemicals (Japan)
• 10.6. UPL (India)
• 10.7. Israel Chemical Company (Israel)
• 10.8. Novozymes A/S (Denmark)
• 10.9. Syngenta Crop Protection AG (Switzerland)